GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and GIP/GLP-1 dual agonists (tirzepatide) carry the clinical evidence: STEP (semaglutide, NEJM 2021), SURMOUNT (tirzepatide, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)
The -cyclodextrin complex of the Moringa isothiocyanate suppresses lipopolysaccharide-induced inflammation in RAW 2647 macrophage cells through Akt and p38 inhibition
For ongoing food and nutrition tracking beyond any GLP-1 program, NutriScan helps you log meals with photo scanning and monitor your daily protein, fiber, and calorie intake
Select your injection site and clean the area with an alcohol swab in a circular motion, starting from the center and moving outward